Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Goldman Sachs Analyst Reaffirms Sell Rating on Franklin Resources

Elaine Mendonca by Elaine Mendonca
March 12, 2024
in Breaking News
0
Unlocking Value: The Economic Potential of Iron-Titanium-Vanadium Projects
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

Goldman Sachs analyst Alexander Blostein reaffirmed his Sell rating on Franklin Resources (NYSE:BEN) on March 12, 2024, while increasing the price target from $26.25 to $26.75. This decision is consistent with Goldman Sachs’ continued bearish outlook on Franklin Resources. Blostein’s updated valuation of the company’s stock takes into account current market conditions and financial performance metrics.

ESTA Stock Shows Positive Momentum on March 12, 2024 with 1.17% Increase

On March 12, 2024, ESTA stock showed positive momentum as it traded in the middle of its 52-week range and above its 200-day simple moving average. The price of ESTA shares increased by $0.57 since the market last closed, representing a 1.17% rise. ESTA stock opened at $49.88 on March 12, which was $1.15 higher than its previous close. Overall, ESTA stock had a strong performance on March 12, with positive price momentum and a significant increase in value. Investors who have been holding ESTA shares may be pleased with the stock’s performance on this day.

ESTA Stock Analysis: Flat Total Revenue but Positive EPS Growth Raises Investor Interest

On March 12, 2024, ESTA stock had a mixed performance based on the financial data provided by CNN Money. The total revenue for the company was reported at $165.15 million for the past year, with a quarterly revenue of $31.56 million. It is worth noting that the total revenue has remained flat since last year and also since the last quarter.

In terms of net income, ESTA reported a net loss of $78.50 million for the past year, with a quarterly net loss of $20.54 million. The net income decreased by 4.38% since last year but remained unchanged since the last quarter.

Earnings per share (EPS) for ESTA stock was reported at -$3.07 for the past year and -$0.79 for the last quarter. The EPS increased by 0.28% since last year and showed a significant increase of 29.9% since the last quarter.

Investors and analysts will be closely monitoring the financial performance of ESTA in the upcoming quarters to see if the company can sustain its positive EPS growth and potentially turn around its net income figures.

Tags: ESTA
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Healthcare Services Stock Exchange

Universal Health Services NYSE UHS Upgraded to Sector Perform with Increased Price Target

Redefining Success: How Franchises Adapt to Economic Shifts and Market Demands

Title Analysis of Options Trading Activity for Riot Platforms NASDAQ RIOT on March 12 2024

The Rise of Strategic Partnerships in Life Sciences: Trends Shaping the Future of Healthcare Innovation

ClearOne Inc Announces Special Dividend and Growth Strategy

Recommended

Torrid Holdings Stock

Torrid Holdings Faces Critical Earnings Test

5 months ago
Take-Two Stock

Take-Two Shares in Holding Pattern as Investors Await GTA VI Details

6 months ago
Union Pacific Stock

Union Pacific’s Future Hangs in Balance as Historic Railroad Merger Faces Critical Vote

4 months ago
Biotechnology Markets and money

BioTechnes Quarterly Earnings and Stock Performance Analysis

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Claros Mortgage Trust Secures Financial Flexibility Through Strategic Debt Overhaul

Trending

Vigil Neuroscience Stock
Healthcare

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

by SiterGedge
February 7, 2026
0

The integration of Vigil Neuroscience into French pharmaceutical giant Sanofi has been finalized. This strategic move, which...

Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026
Potbelly Stock

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success
  • Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com